Latest article
Lilly and Biolojic Design Announce Analysis Collaboration to Uncover and Develop Antibody Therapies for...
INDIANAPOLIS and TEL AVIV, March 8, 2021 / PRNewswire / - Eli Lilly and Company (NYSE: LLY) and Biolojic Design Ltd. ("Biolojic"), a...
Bayer’s Finerenone Meets Major Endpoint in Section III FIGARO-DKD Cardiovascular Outcomes Research in Sufferers...
WHIPPANY, NJ - (BUSINESS WIRE) - Bayer's phase III cardiovascular outcome study FIGARO-DKD evaluating the efficacy...